Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ligand Pharmaceuticals (LGNDZ) Shares Outstanding (Diluted Average) (2016 - 2025)

Ligand Pharmaceuticals (LGNDZ) has disclosed Shares Outstanding (Diluted Average) for 16 consecutive years, with $20.3 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding (Diluted Average) rose 10.96% to $20.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $20.3 million through Dec 2025, up 10.96% year-over-year, with the annual reading at $20.3 million for FY2025, 10.96% up from the prior year.
  • Shares Outstanding (Diluted Average) hit $20.3 million in Q4 2025 for Ligand Pharmaceuticals, up from $20.2 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $20.3 million in Q4 2025 to a low of $16.8 million in Q1 2022.
  • Historically, Shares Outstanding (Diluted Average) has averaged $18.0 million across 5 years, with a median of $17.8 million in 2023.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): decreased 2.46% in 2022 and later increased 10.96% in 2025.
  • Year by year, Shares Outstanding (Diluted Average) stood at $17.2 million in 2021, then decreased by 2.19% to $16.9 million in 2022, then rose by 5.27% to $17.8 million in 2023, then rose by 3.0% to $18.3 million in 2024, then rose by 10.96% to $20.3 million in 2025.
  • Business Quant data shows Shares Outstanding (Diluted Average) for LGNDZ at $20.3 million in Q4 2025, $20.2 million in Q3 2025, and $19.3 million in Q2 2025.